Tabula Rasa enables medication optimization using its medication risk mitigation technology.
Tabula Rasa provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 25, 2021 | Grant | $1.90M | 1 |
National Institutes of Health
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
Yes | Grant |